The European Commission has launched a public consultation on the draft implementing act on joint scientific consultations on medicinal products for human use at Union level under the Health Technology Assessment (HTA) Regulation.
The HTA Regulation aims to support cooperation between European countries to clinically assess new health technologies, optimising the use of health system resources while maintaining respect for national competencies.
The current public consultation is focused specifically on the implementation of joint scientific consultations under the HTA Regulation. This initiative sets out implementing rules detailing how developers could receive early guidance on the evidence and data needed to carry out a joint clinical assessment of their product.
The consultation is already open, and will close on 29 October 2024. Responses can be submitted in any of the 24 official European languages.